knowledge -WSS

knowledge

author：hotspot 2025-08-23 08:52:51 - browse：9144

Kidney transplants are the most common organ transplant procedure in the U.S., with 25,000 taking place in 2022. But for patients who receive new kidneys, the transplant is often followed by severe lifelong challenges, many of which are linked to the immunosuppression drug regimen required after surgery to ensure the body does not reject the new organ. These treatments have side effects and toxicities that impact patients’ long-term health, and even survival, leading to a transplant failure rate of 30-50% at the 10-year mark.

Now a new trial sponsored by Medeor Therapeutics, the results of which were presented Thursday at the American Society of Nephrology (ASN) Kidney Week 2023 Annual Meeting, offers hope that stem cell therapy may help patients discontinue their immunosuppressant regime within a year of the transplant.

“The ability to get a transplant without being on lifelong immunosuppression is kind of a dream in transplant, so I can see why this would generate a lot of excitement,” said Sommer Gentry, a professor of surgery at New York University, who was not involved in the study and was not at the actual presentation, but reviewed the trial’s presentation slides.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Brain injuries and the importance of a second opinion

knowledge

WSS

Gene therapy’s promise and the high cost of hope

Humans aren't the only ones with an imagination. Rats have it too

Accuser who called Kevin Spacey 'vile sexual predator' admits he joked about incident

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

Sarepta Duchenne therapy fails to meet primary endpoint in trial

Infant mortality in U.S. rose last year for first time in decades: CDC

knowledge

knowledge

entertainment

Peter Hotez and the public health issue of online harassment

Coloradans with cystic fibrosis could lose access to Trikafta

Virginia high school admissions case could be legal follow

STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

Duchenne breakthrough therapy leaves behind pioneering families

See Ryan Reynolds, Hugh Jackman suited up in 1st look at 'Deadpool 3': Photo

Guidelines to prevent youth baseball injuries need more muscle

Giraffe named Twiga, who was among the oldest cared for by humans, died at age 31 at East Texas zoo

After affirmative action ruling, medical educators look to 'holistic review'

Pandemic and All Hazards Preparedness Act needs lean update

entertainment

Travis Kelce and the trap of celebrity vaccine endorsements

Nevada Republican Sam Brown launching another Senate bid, teeing up marquee race

Readout LOUD podcast: ESMO highlights & Roivant's big deal

Inari Medical to buy amputation prevention company LimFlow

Teachers share how revamped forgiveness program helped with their student loans

Teachers share how revamped forgiveness program helped with their student loans

knowledge

leisure time

hotspot

explore